The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2023 | Emerging strategies to support patients with hemophilia A
Riitta Lassila
• 10 Jun 2023
Riitta Lassila, MD, PhD, University of Helsinki, Helsinki, Finland, discusses recent developments in the treatment of hemophilia, mentioning the benefits of new drugs and strategies such as emicizumab. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
